home / stock / redif / redif short
Short Information | Redhill Biopharma Ltd Ord (OTCMKTS:REDIF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 47,093 |
Total Actual Volume | 55,093 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 14 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 2,355 |
Average Short Percentage | 70.10% |
Is there a REDIF Short Squeeze or Breakout about to happen?
See the REDIF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
02-07-2020 | $N/A | $0.67 | $N/A | $N/A | 90 | 90 | 100% |
01-24-2020 | $N/A | $0.67 | $N/A | $N/A | 90 | 90 | 100% |
01-09-2020 | $N/A | $0.67 | $N/A | $N/A | 90 | 90 | 100% |
12-05-2019 | $0.67 | $0.67 | $0.67 | $0.67 | 30,000 | 30,000 | 100% |
12-03-2019 | $0.70 | $0.70 | $0.70 | $0.70 | 10,000 | 10,000 | 100% |
11-25-2019 | $0.705 | $0.705 | $0.705 | $0.705 | 2,030 | 2,030 | 100% |
07-22-2019 | $N/A | $0.79 | $N/A | $N/A | 63 | 63 | 100% |
07-17-2019 | $0.95 | $0.79 | $0.95 | $0.79 | 8,160 | 160 | 1.96% |
07-15-2019 | $0.875 | $0.875 | $0.875 | $0.875 | 1,000 | 1,000 | 100% |
06-14-2019 | $0.785 | $0.785 | $0.785 | $0.785 | 1,160 | 1,160 | 100% |
05-06-2019 | $0.77 | $0.77 | $0.77 | $0.77 | 160 | 160 | 100% |
03-05-2019 | $0.78 | $0.78 | $0.78 | $0.78 | 750 | 750 | 100% |
08-21-2018 | $0.75 | $0.75 | $0.75 | $0.75 | 500 | 500 | 100% |
08-02-2018 | $0.75 | $0.75 | $0.75 | $0.75 | 500 | 500 | 100% |
07-09-2018 | $0.97 | $0.97 | $0.97 | $0.97 | 500 | 500 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd Ord Company Name:
REDIF Stock Symbol:
OTCMKTS Market:
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results Canada NewsWire RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein mutation...
RedHill Biopharma Announces Closing of $15.5 Million Public Offering of American Depositary Shares PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Nov. 23, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty b...
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients Canada NewsWire - Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107...